{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T05:30:50Z","timestamp":1790314250030,"version":"4.1.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T00:00:00Z","timestamp":1741046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T00:00:00Z","timestamp":1741046400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-10677-0","type":"journal-article","created":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T04:59:32Z","timestamp":1741064372000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Development of a Weighted-Incidence Syndromic Combination Antibiogram (WISCA) to guide empiric antibiotic treatment for ventilator-associated pneumonia in a Mexican tertiary care university hospital"],"prefix":"10.1186","volume":"25","author":[{"given":"Jaime","family":"Briseno-Ram\u00edrez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adolfo","family":"G\u00f3mez-Quiroz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda Berenice","family":"Avila-Cardenas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith Carolina","family":"De Arcos-Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Perales-Guerrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime F.","family":"Andrade-Villanueva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Mart\u00ednez-Ayala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,4]]},"reference":[{"issue":"5","key":"10677_CR1","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.ajic.2011.05.020","volume":"40","author":"VD Rosenthal","year":"2012","unstructured":"Rosenthal VD, Bijie H, Maki DG, et al. International nosocomial infection control consortium (INICC) report, data summary of 36 countries, for 2004\u20132009. Am J Infect Control. 2012;40(5):396\u2013407. https:\/\/doi.org\/10.1016\/j.ajic.2011.05.020.","journal-title":"Am J Infect Control"},{"issue":"5","key":"10677_CR2","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1097\/01.CCM.0000063087.93157.06","volume":"31","author":"DK Warren","year":"2003","unstructured":"Warren DK, Shukla SJ, Olsen MA, et al. Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center. Crit Care Med. 2003;31(5):1312\u20137. https:\/\/doi.org\/10.1097\/01.CCM.0000063087.93157.06.","journal-title":"Crit Care Med"},{"key":"10677_CR3","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1093\/cid\/ciy543","volume":"68","author":"A Bonell","year":"2018","unstructured":"Bonell A, Azarrafiy R, Huong V, Viet T, Phu V, Dat V, Wertheim H, Wertheim H, Doorn H, Lewycka S, Nadjm B. A systematic review and Meta-analysis of Ventilator-associated pneumonia in adults in Asia: an analysis of National income level on incidence and etiology. Clin Infect Diseases: Official Publication Infect Dis Soc Am. 2018;68:511\u20138. https:\/\/doi.org\/10.1093\/cid\/ciy543.","journal-title":"Clin Infect Diseases: Official Publication Infect Dis Soc Am"},{"key":"10677_CR4","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1097\/01.CCM.0000181731.53912.D9","volume":"33","author":"N Safdar","year":"2005","unstructured":"Safdar N, Dezfulian C, Collard H, Saint S. Clinical and economic consequences of ventilator-associated pneumonia: A systematic review. Crit Care Med. 2005;33:2184\u201393. https:\/\/doi.org\/10.1097\/01.CCM.0000181731.53912.D9.","journal-title":"Crit Care Med"},{"issue":"1","key":"10677_CR5","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3390\/antibiotics13010002","volume":"13","author":"GG Cabrera-Tejada","year":"2023","unstructured":"Cabrera-Tejada GG, Chico-S\u00e1nchez P, Gras-Valent\u00ed P, Jaime-S\u00e1nchez FA, Galiana-Ivars M, Balboa-Esteve S, G\u00f3mez-Sotero IL, S\u00e1nchez-Pay\u00e1 J, Ronda-P\u00e9rez E. Estimation of additional costs in patients with Ventilator-Associated pneumonia. Antibiot (Basel). 2023;13(1):2. https:\/\/doi.org\/10.3390\/antibiotics13010002.","journal-title":"Antibiot (Basel)"},{"issue":"10","key":"10677_CR6","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1097\/01.ccm.0000181731.53912.d9","volume":"33","author":"N Safdar","year":"2005","unstructured":"Safdar N, Dezfulian C, Collard HR, Saint S. Clinical and economic consequences of ventilator-associated pneumonia: a systematic review. Crit Care Med. 2005;33(10):2184\u201393. https:\/\/doi.org\/10.1097\/01.ccm.0000181731.53912.d9.","journal-title":"Crit Care Med"},{"issue":"12","key":"10677_CR7","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1086\/502349","volume":"25","author":"S Hugonnet","year":"2004","unstructured":"Hugonnet S, Eggimann P, Borst F, Maricot P, Chevrolet JC, Pittet D. Impact of ventilator-associated pneumonia on resource utilization and patient outcome. Infect Control Hosp Epidemiol. 2004;25(12):1090\u20136. https:\/\/doi.org\/10.1086\/502349.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"3","key":"10677_CR8","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1086\/664049","volume":"33","author":"MH Kollef","year":"2012","unstructured":"Kollef MH, Hamilton CW, Ernst FR. Economic impact of ventilator-associated pneumonia in a large matched cohort. Infect Control Hosp Epidemiol. 2012;33(3):250\u20136. https:\/\/doi.org\/10.1086\/664049. Epub 2012 Jan 17.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10677_CR9","doi-asserted-by":"publisher","first-page":"482","DOI":"10.3389\/fphar.2019.00482","volume":"10","author":"D Wu","year":"2019","unstructured":"Wu D, Wu C, Zhang S, Zhong Y. Risk factors of Ventilator-Associated pneumonia in critically III patients. Front Pharmacol. 2019;10:482. https:\/\/doi.org\/10.3389\/fphar.2019.00482.","journal-title":"Front Pharmacol"},{"issue":"4","key":"10677_CR10","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.21037\/jtd-23-425","volume":"15","author":"S Chen","year":"2023","unstructured":"Chen S, Gao G, Xia Y, Wu Z. Incidence rate and risk factors of ventilator-associated pneumonia in patients with traumatic brain injury: a systematic review and meta-analysis of observational studies. J Thorac Dis. 2023;15(4):2068\u201378. https:\/\/doi.org\/10.21037\/jtd-23-425. Epub 2023 Apr 27.","journal-title":"J Thorac Dis"},{"key":"10677_CR11","doi-asserted-by":"publisher","first-page":"7272080","DOI":"10.1155\/2017\/7272080","volume":"2017","author":"L Chang","year":"2017","unstructured":"Chang L, Dong Y, Zhou P. Investigation on risk factors of Ventilator-Associated pneumonia in acute cerebral hemorrhage patients in intensive care unit. Can Respir J. 2017;2017:7272080. https:\/\/doi.org\/10.1155\/2017\/7272080. Epub 2017 Dec 17.","journal-title":"Can Respir J"},{"issue":"1","key":"10677_CR12","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1007\/s12028-019-00773-w","volume":"32","author":"Y Li","year":"2020","unstructured":"Li Y, Liu C, Xiao W, Song T, Wang S, Incidence. Risk factors, and outcomes of Ventilator-Associated pneumonia in traumatic brain injury: A Meta-analysis. Neurocrit Care. 2020;32(1):272\u201385. https:\/\/doi.org\/10.1007\/s12028-019-00773-w.","journal-title":"Neurocrit Care"},{"key":"10677_CR13","doi-asserted-by":"publisher","first-page":"9730895","DOI":"10.1155\/2022\/9730895","volume":"2022","author":"S Yohannes","year":"2022","unstructured":"Yohannes S, Ahmed Z, Schelling R, Perinkulam Sathyanarayanan S, Pratt A, Schreiber MP. Incidence and impact of ventilator associated multidrug resistant pneumonia in patients with SARS-COV2. Crit Care Res Pract. 2022;2022:9730895. https:\/\/doi.org\/10.1155\/2022\/9730895.","journal-title":"Crit Care Res Pract"},{"issue":"6","key":"10677_CR14","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.jinf.2019.09.012","volume":"79","author":"S Mohd Sazlly Lim","year":"2019","unstructured":"Mohd Sazlly Lim S, Zainal Abidin A, Liew SM, Roberts JA, Sime FB. The global prevalence of multidrug-resistance among Acinetobacter baumannii causing hospital-acquired and ventilator-associated pneumonia and its associated mortality: A systematic review and meta-analysis. J Infect. 2019;79(6):593\u2013600. Epub 2019 Sep 30.","journal-title":"J Infect"},{"key":"10677_CR15","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jgar.2016.12.016","volume":"9","author":"R Gupta","year":"2017","unstructured":"Gupta R, Malik A, Rizvi M, Ahmed M, Singh A. Epidemiology of multidrug-resistant Gram-negative pathogens isolated from ventilator-associated pneumonia in ICU patients. J Glob Antimicrob Resist. 2017;9:47\u201350. Epub 2017 Apr 10.","journal-title":"J Glob Antimicrob Resist"},{"key":"10677_CR16","doi-asserted-by":"publisher","unstructured":"Zaragoza R, Vidal-Cort\u00e9s P, Aguilar G, Borges M, D\u00edaz E, Ferrer R, Maseda E, Nieto M, Nuvials F, Ram\u00edrez P, Rodr\u00edguez A, Soriano C, Veganzones J, Mart\u00edn-Loeches I. Update of the treatment of nosocomial pneumonia in the ICU. Crit Care. 2020;24. https:\/\/doi.org\/10.1186\/s13054-020-03091-2.","DOI":"10.1186\/s13054-020-03091-2"},{"issue":"1","key":"10677_CR17","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1186\/s12879-021-06383-2","volume":"21","author":"W Luo","year":"2021","unstructured":"Luo W, Xing R, Wang C. The effect of ventilator- associated pneumonia on the prognosis of intensive care unit patients within 90 days and 180 days. BMC Infect Dis. 2021;21(1):684. https:\/\/doi.org\/10.1186\/s12879-021-06383-2.","journal-title":"BMC Infect Dis"},{"issue":"5","key":"10677_CR18","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.ijantimicag.2015.07.010","volume":"46","author":"V Fihman","year":"2015","unstructured":"Fihman V, Messika J, Hajage D, et al. Five-year trends for ventilator-associated pneumonia: correlation between Microbiological findings and antimicrobial drug consumption. Int J Antimicrob Agents. 2015;46(5):518\u201325. https:\/\/doi.org\/10.1016\/j.ijantimicag.2015.07.010.","journal-title":"Int J Antimicrob Agents"},{"key":"10677_CR19","doi-asserted-by":"publisher","first-page":"3903","DOI":"10.2147\/IDR.S234610","volume":"12","author":"P Dadgostar","year":"2019","unstructured":"Dadgostar P. Antimicrobial resistance: implications and costs. Infect Drug Resist. 2019;12:3903\u201310. https:\/\/doi.org\/10.2147\/IDR.S234610.","journal-title":"Infect Drug Resist"},{"key":"10677_CR20","doi-asserted-by":"publisher","unstructured":"Hay S, Rao P, Dolecek C, Day N, Stergachis A, Lopez A, Murray C. Measuring and mapping the global burden of antimicrobial resistance. BMC Med. 2018;16. https:\/\/doi.org\/10.1186\/s12916-018-1073-z.","DOI":"10.1186\/s12916-018-1073-z"},{"key":"10677_CR21","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1179\/2047773215Y.0000000030","volume":"109","author":"F Prestinaci","year":"2015","unstructured":"Prestinaci F, Pezzotti P, Pantosti A. Antimicrobial resistance: a global multifaceted phenomenon. Pathogens Global Health. 2015;109:309\u201318. https:\/\/doi.org\/10.1179\/2047773215Y.0000000030.","journal-title":"Pathogens Global Health"},{"issue":"7","key":"10677_CR22","doi-asserted-by":"publisher","first-page":"203","DOI":"10.2147\/IDR.S67267","volume":"16","author":"K Chittawatanarat","year":"2014","unstructured":"Chittawatanarat K, Jaipakdee W, Chotirosniramit N, et al. Microbiology, resistance patterns, and risk factors of mortality in ventilator-associated bacterial pneumonia in a Northern Thai tertiary-care university based general surgical intensive care unit. Infect Drug Resist. 2014;16(7):203\u201310. https:\/\/doi.org\/10.2147\/IDR.S67267.","journal-title":"Infect Drug Resist"},{"key":"10677_CR23","doi-asserted-by":"publisher","unstructured":"Sch\u00f6nherr S, Ranft D, Lippmann N, L\u00fcbbert C. Changes in antibiotic consumption, AMR and Clostridioides difficile infections in a large tertiary-care center following the implementation of institution-specific guidelines for antimicrobial therapy: A nine-year interrupted time series study. PLoS ONE. 2021;16. https:\/\/doi.org\/10.1371\/journal.pone.0258690.","DOI":"10.1371\/journal.pone.0258690"},{"key":"10677_CR24","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1080\/22221751.2022.2030196","volume":"11","author":"O Ayobami","year":"2022","unstructured":"Ayobami O, Brinkwirth S, Eckmanns T, Markwart R. Antibiotic resistance in hospital-acquired ESKAPE-E infections in low- and lower-middle-income countries: a systematic review and meta-analysis. Emerg Microbes Infections. 2022;11:443\u201351. https:\/\/doi.org\/10.1080\/22221751.2022.2030196.","journal-title":"Emerg Microbes Infections"},{"issue":"3","key":"10677_CR25","doi-asserted-by":"publisher","first-page":"1700582","DOI":"10.1183\/13993003.00582-2017","volume":"50","author":"A Torres","year":"2017","unstructured":"Torres A, Niederman MS, Chastre J, et al. International ERS\/ESICM\/ESCMID\/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia: guidelines for the management of hospital-acquired pneumonia (HAP)\/ventilator-associated pneumonia (VAP) of the European respiratory society (ERS), European society of intensive care medicine (ESICM), European society of clinical microbiology and infectious diseases (ESCMID) and asociaci\u00f3n Latinoamericana Del t\u00f3rax (ALAT). Eur Respir J. 2017;50(3):1700582. https:\/\/doi.org\/10.1183\/13993003.00582-2017.","journal-title":"Eur Respir J"},{"issue":"8","key":"10677_CR26","doi-asserted-by":"publisher","first-page":"582","DOI":"10.7326\/0003-4819-145-8-200610170-00007","volume":"145","author":"VD Rosenthal","year":"2006","unstructured":"Rosenthal VD, Maki DG, Salomao R, International Nosocomial Infection Control Consortium, et al. Device-associated nosocomial infections in 55 intensive care units of 8 developing countries. Ann Intern Med. 2006;145(8):582\u201391. https:\/\/doi.org\/10.7326\/0003-4819-145-8-200610170-00007.","journal-title":"Ann Intern Med"},{"key":"10677_CR27","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1378\/chest.115.2.462","volume":"115","author":"MH Kollef","year":"1999","unstructured":"Kollef MH, Sherman G, Ward S, Fraser VJ. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest. 1999;115:462\u201374.","journal-title":"Chest"},{"issue":"4","key":"10677_CR28","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1086\/664768","volume":"33","author":"C Hebert","year":"2012","unstructured":"Hebert C, Ridgway J, Vekhter B, Brown EC, Weber SG, Robicsek A. Demonstration of the weighted-incidence syndromic combination antibiogram: an empiric prescribing decision aid. Infect Control Hosp Epidemiol. 2012;33(4):381\u20138. https:\/\/doi.org\/10.1086\/664768.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"2","key":"10677_CR29","doi-asserted-by":"publisher","first-page":"e1921150","DOI":"10.1001\/jamanetworkopen.2019.21150","volume":"3","author":"JJH Park","year":"2020","unstructured":"Park JJH, Murthy S. Defining optimal empirical antibiotic regimens in a rapidly changing landscape of resistance. JAMA Netw Open. 2020;3(2):e1921150. https:\/\/doi.org\/10.1001\/jamanetworkopen.2019.21150.","journal-title":"JAMA Netw Open"},{"issue":"2","key":"10677_CR30","doi-asserted-by":"publisher","first-page":"e1921124","DOI":"10.1001\/jamanetworkopen.2019.21124","volume":"3","author":"JA Bielicki","year":"2020","unstructured":"Bielicki JA, Sharland M, Heath PT, et al. Evaluation of the coverage of 3 antibiotic regimens for neonatal sepsis in the hospital setting across Asian countries. JAMA Netw Open. 2020;3(2):e1921124. https:\/\/doi.org\/10.1001\/jamanetworkopen.2019.21124.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10677_CR31","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13756-021-00939-2","volume":"10","author":"E Barbieri","year":"2021","unstructured":"Barbieri E, Bottigliengo D, Tellini M, Minotti C, Marchiori M, Cavicchioli P, Gregori D, Giaquinto C, Da Dalt L, Don\u00e0 D. Development of a Weighted-Incidence syndromic combination antibiogram (WISCA) to guide the choice of the empiric antibiotic treatment for urinary tract infection in paediatric patients: a bayesian approach. Antimicrob Resist Infect Control. 2021;10(1):74. https:\/\/doi.org\/10.1186\/s13756-021-00939-2.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"3","key":"10677_CR32","doi-asserted-by":"publisher","first-page":"R112","DOI":"10.1186\/cc13901","volume":"18","author":"V Randhawa","year":"2014","unstructured":"Randhawa V, Sarwar S, Walker S, Elligsen M, Palmay L, Daneman N. Weighted-incidence syndromic combination antibiograms to guide empiric treatment of critical care infections: a retrospective cohort study. Crit Care. 2014;18(3):R112. https:\/\/doi.org\/10.1186\/cc13901.","journal-title":"Crit Care"},{"issue":"1","key":"10677_CR33","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12941-024-00673-8","volume":"23","author":"C Liberati","year":"2024","unstructured":"Liberati C, Don\u00e0 D, Maestri L, Petris MG, Barbieri E, Gallo E, Gallocchio J, Pierobon M, Calore E, Zin A, Brigadoi G, Mariani M, Mesini A, Saffioti C, Ugolotti E, Gregori D, Giaquinto C, Castagnola E, Biffi A. Application of the Weighted-Incidence syndromic combination antibiogram (WISCA) to guide the empiric antibiotic treatment of febrile neutropenia in oncological paediatric patients: experience from two paediatric hospitals in Northern Italy. Ann Clin Microbiol Antimicrob. 2024;23(1):16. https:\/\/doi.org\/10.1186\/s12941-024-00673-8.","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"4","key":"10677_CR34","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1164\/rccm.200405-644ST","volume":"171","author":"American Thoracic Society; Infectious Diseases Society of America","year":"2005","unstructured":"American Thoracic Society; Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005;171(4):388\u2013416. https:\/\/doi.org\/10.1164\/rccm.200405-644ST.","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10677_CR35","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1093\/cid\/ciw353","volume":"63","author":"AC Kalil","year":"2016","unstructured":"Kalil AC, Metersky ML, Klompas M, Muscedere J, Sweeney DA, Palmer LB, Napolitano LM, O\u2019Grady NP, Bartlett JG, Carratal\u00e0 J, El Solh AA, Ewig S, Fey PD, File TM Jr, Restrepo MI, Roberts JA, Waterer GW, Cruse P, Knight SL, Brozek JL. Management of adults with Hospital-acquired and Ventilator-associated pneumonia: 2016 clinical practice guidelines by the infectious diseases society of America and the American thoracic society. Clin Infect Dis. 2016;63(5):e61\u2013111. https:\/\/doi.org\/10.1093\/cid\/ciw353. Epub 2016 Jul 14.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10677_CR36","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1164\/rccm.202303-0558WS","volume":"209","author":"MA Matthay","year":"2024","unstructured":"Matthay MA, Arabi Y, Arroliga AC, Bernard G, Bersten AD, Brochard LJ, Calfee CS, Combes A, Daniel BM, Ferguson ND, Gong MN, Gotts JE, Herridge MS, Laffey JG, Liu KD, Machado FR, Martin TR, McAuley DF, Mercat A, Moss M, Mularski RA, Pesenti A, Qiu H, Ramakrishnan N, Ranieri VM, Riviello ED, Rubin E, Slutsky AS, Thompson BT, Twagirumugabe T, Ware LB, Wick KD. A new global definition of acute respiratory distress syndrome. Am J Respir Crit Care Med. 2024;209(1):37\u201347. https:\/\/doi.org\/10.1164\/rccm.202303-0558WS.","journal-title":"Am J Respir Crit Care Med"},{"key":"10677_CR37","unstructured":"Clinical and Laboratory Standards Institute. (2024). Performance standards for antimicrobial susceptibility testing (34th ed.). Clinical and Laboratory Standards Institute. https:\/\/clsi.org\/standards\/products\/microbiology\/documents\/m100\/"},{"key":"10677_CR38","unstructured":"Clinical and Laboratory Standards Institute. (2018). Performance standards for antimicrobial susceptibility testing (28th ed.). Clinical and Laboratory Standards Institute. https:\/\/clsi.org\/standards\/products\/microbiology\/documents\/m100\/"},{"issue":"3","key":"10677_CR39","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"AP Magiorakos","year":"2012","unstructured":"Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, Paterson DL, Rice LB, Stelling J, Struelens MJ, Vatopoulos A, Weber JT, Monnet DL. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268\u201381. https:\/\/doi.org\/10.1111\/j.1469-0691.2011.03570.x.","journal-title":"Clin Microbiol Infect"},{"key":"10677_CR40","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1007\/s00228-015-1865-4","volume":"71","author":"A Javan","year":"2015","unstructured":"Javan A, Shokouhi S, Sahraei Z. A review on colistin nephrotoxicity. Eur J Clin Pharmacol. 2015;71:801\u201310. https:\/\/doi.org\/10.1007\/s00228-015-1865-4.","journal-title":"Eur J Clin Pharmacol"},{"key":"10677_CR41","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1007\/s12325-020-01235-y","volume":"37","author":"L Zha","year":"2020","unstructured":"Zha L, Pan L, Guo J, et al. Effectiveness and safety of high dose Tigecycline for the treatment of severe infections: A systematic review and Meta-Analysis. Adv Ther. 2020;37:1049\u201364. https:\/\/doi.org\/10.1007\/s12325-020-01235-y.","journal-title":"Adv Ther"},{"key":"10677_CR42","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s40121-019-0251-4","volume":"8","author":"J Kuti","year":"2019","unstructured":"Kuti J, Kim A, Cloutier D, Nicolau D. Evaluation of Plazomicin, Tigecycline, and meropenem pharmacodynamic exposure against Carbapenem-Resistant Enterobacteriaceae in patients with bloodstream infection or Hospital-Acquired\/Ventilator-Associated pneumonia from the CARE study (ACHN-490-007). Infect Dis Therapy. 2019;8:383\u201396. https:\/\/doi.org\/10.1007\/s40121-019-0251-4.","journal-title":"Infect Dis Therapy"},{"issue":"1","key":"10677_CR43","first-page":"27","volume":"18","author":"D Curcio","year":"2010","unstructured":"Curcio D, Castagnino J, Vazquez W, Vergara G, Curiale A. Latin American Tigecycline use registry for ventilator associated pneumonia (LatinVAP). Tigecycline in the treatment of ventilator-associated pneumonia: experience from the Latin American Tigecycline use registry. Infez Med. 2010;18(1):27\u201334.","journal-title":"Infez Med"},{"key":"10677_CR44","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1007\/s00134-015-4010-z","volume":"41","author":"A Chaari","year":"2015","unstructured":"Chaari A, Pham T, Mnif B, Chtara K, Medhioub F, Baccouche N, Bahloul M, Hammami A, Bouaziz M. Colistin\u2013tigecycline versus colistin\u2013imipenem\u2013cilastatin combinations for the treatment of Acinetobacter baumannii ventilator-acquired pneumonia: a prognosis study. Intensive Care Med. 2015;41:2018\u20139. https:\/\/doi.org\/10.1007\/s00134-015-4010-z.","journal-title":"Intensive Care Med"},{"issue":"3","key":"10677_CR45","doi-asserted-by":"publisher","first-page":"120","DOI":"10.5414\/CP203102","volume":"56","author":"Y Qin","year":"2018","unstructured":"Qin Y, Zhang J, Wu L, Zhang D, Fu L, Xue X. Comparison of the treatment efficacy between Tigecycline plus high-dose cefoperazone-sulbactam and Tigecycline monotherapy against ventilator-associated pneumonia caused by extensively drug-resistant Acinetobacter baumannii. Int J Clin Pharmacol Ther. 2018;56(3):120\u20139. https:\/\/doi.org\/10.5414\/CP203102.","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10677_CR46","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.2147\/IDR.S249352","volume":"13","author":"XR Bai","year":"2020","unstructured":"Bai XR, Jiang DC, Yan SY. High-Dose Tigecycline in elderly patients with pneumonia due to Multidrug-Resistant Acinetobacter baumannii in intensive care unit. Infect Drug Resist. 2020;13:1447\u201354. https:\/\/doi.org\/10.2147\/IDR.S249352.","journal-title":"Infect Drug Resist"},{"key":"10677_CR47","doi-asserted-by":"publisher","DOI":"10.37766\/inplasy2023.4.0034","author":"C Feng","year":"2023","unstructured":"Feng C, Yang X, Lu J, Mo Q, Cai Z, Zhu W. Systematic evaluation and Meta-analysis of the efficacy and safety of different doses of Tigecycline in ventilator-associated pneumonia caused by multiple resistant bacteria. Archives Med Sci. 2023. https:\/\/doi.org\/10.37766\/inplasy2023.4.0034.","journal-title":"Archives Med Sci"},{"issue":"10","key":"10677_CR48","doi-asserted-by":"publisher","first-page":"CD004267","DOI":"10.1002\/14651858.CD004267.pub4","volume":"10","author":"LE Arthur","year":"2016","unstructured":"Arthur LE, Kizor RS, Selim AG, van Driel ML, Seoane L. Antibiotics for ventilator-associated pneumonia. Cochrane Database Syst Rev. 2016;10(10):CD004267. https:\/\/doi.org\/10.1002\/14651858.CD004267.pub4.","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10677_CR49","doi-asserted-by":"publisher","first-page":"196","DOI":"10.7196\/SAMJ.2016.v106i2.9870","volume":"106","author":"Y Ramsamy","year":"2016","unstructured":"Ramsamy Y, Muckart DJ, Bruce JL, Hardcastle TC, Han KS, Mlisana KP. Empirical antimicrobial therapy for probable V. directed therapy for possible V.ntilator-associated pneumonia in critically injured patients. S Afr Med J. 2016;106(2):196\u2013200. https:\/\/doi.org\/10.7196\/SAMJ.2016.v106i2.9870.","journal-title":"S Afr Med J"},{"issue":"3","key":"10677_CR50","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1378\/CHEST.123.3.835","volume":"123","author":"R Fowler","year":"2003","unstructured":"Fowler R, Flavin K, Barr J, Weinacker A, Parsonnet J, Gould M. Variability in antibiotic prescribing patterns and outcomes in patients with clinically suspected ventilator-associated pneumonia. Chest. 2003;123(3):835\u201344. https:\/\/doi.org\/10.1378\/CHEST.123.3.835.","journal-title":"Chest"},{"issue":"2","key":"10677_CR51","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1378\/chest.08-1116","volume":"134","author":"K Kollef","year":"2008","unstructured":"Kollef K, Schramm G, Wills A, Reichley R, Micek S, Kollef M. Predictors of 30-day mortality and hospital costs in patients with ventilator-associated pneumonia attributed to potentially antibiotic-resistant gram-negative bacteria. Chest. 2008;134(2):281\u20137. https:\/\/doi.org\/10.1378\/chest.08-1116.","journal-title":"Chest"},{"issue":"3","key":"10677_CR52","doi-asserted-by":"publisher","first-page":"e0247832","DOI":"10.1371\/journal.pone.0247832","volume":"16","author":"S Kharel","year":"2021","unstructured":"Kharel S, Bist A, Mishra SK. Ventilator-associated pneumonia among ICU patients in WHO Southeast Asian region: A systematic review. PLoS ONE. 2021;16(3):e0247832. https:\/\/doi.org\/10.1371\/journal.pone.0247832.","journal-title":"PLoS ONE"},{"issue":"6","key":"10677_CR53","doi-asserted-by":"publisher","first-page":"2932","DOI":"10.1097\/MS9.0000000000000836","volume":"85","author":"H Mumtaz","year":"2023","unstructured":"Mumtaz H, Saqib M, Khan W, Ismail SM, Sohail H, Muneeb M, Sheikh SS. Ventilator associated pneumonia in intensive care unit patients: a systematic review. Ann Med Surg (Lond). 2023;85(6):2932\u20139. https:\/\/doi.org\/10.1097\/MS9.0000000000000836.","journal-title":"Ann Med Surg (Lond)"},{"key":"10677_CR54","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.ajic.2011.08.017","volume":"40 7","author":"C Tseng","year":"2012","unstructured":"Tseng C, Liu S, Wang C, Tu M, Chung Y, Lin M, Fang W. Impact of clinical severity index, infective pathogens, and initial empiric antibiotic use on hospital mortality in patients with ventilator-associated pneumonia. Am J Infect Control. 2012;40 7:648\u201352. https:\/\/doi.org\/10.1016\/j.ajic.2011.08.017.","journal-title":"Am J Infect Control"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-10677-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-10677-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-10677-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T04:59:37Z","timestamp":1741064377000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-10677-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,4]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["10677"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-10677-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4714294\/v1","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,4]]},"assertion":[{"value":"9 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study involving humans was approved by the \u201cComit\u00e9 de \u00c9tica en Investigaci\u00f3n en Ciencias de la Salud del Centro Universitario de Tlajomulco, Universidad de Guadalajara\u201d (ethical approval number CUTLAJO\/DS\/CEICS\/018\/24) and conducted in accordance with the Helsinki declaration, national legislation, and institutional requirements. As the study was performed retrospectively and only deidentified data were used, informed consent was waived.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}}],"article-number":"307"}}